Jia Huiqing, Zheng Yan, Wang Ping, Wei Zhimin, Li Xia, Fu Guangming, Wang Chengqin
Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China; Department of Pathology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
Department of Pathology, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
Clin Breast Cancer. 2022 Apr;22(3):e341-e349. doi: 10.1016/j.clbc.2021.09.009. Epub 2021 Sep 29.
To investigate the clinicopathologic characteristics and outcome of bilateral breast cancer (BBC) in the Chinese population.
A retrospective study was conducted on 7797 cases with primary breast cancer, including 7618 cases of unilateral breast cancer (UBC) and 179 cases of BBC. Among the latter, there were 108 cases of synchronous BBC (SBBC) and 71 cases of metachronous BBC (MBBC).
In the present study, the incidence of SBBC and MBBC are 1.39% and 0.91% among the general population, respectively. In comparison of UBC and BBC, SBBC and MBBC, there are significant differences in the common clinicopathological characteristics, such as pathologic stage, hormone receptor (HR) status and molecular type. In respect of the surgical treatment of BBC, 49.72% of the patients chose mastectomy. The 3-year disease free survival (DFS) for SBBC and MBBC are 94.4% and 96.9%, respectively. There is no difference in the overall survival (OS) and DFS between SBBC and MBBC. The histological grade and type of surgery on tumors of both sides are important influencing factors of DFS in the BBC patients.
There are statistical differences in the clinicopathological characteristics and outcomes between SBBC and MBBC among the Chinese population. Therefore, the treatment of BBC patients should be individualized.
探讨中国人群双侧乳腺癌(BBC)的临床病理特征及预后。
对7797例原发性乳腺癌患者进行回顾性研究,其中包括7618例单侧乳腺癌(UBC)和179例BBC。在后者中,有108例同步性BBC(SBBC)和71例异时性BBC(MBBC)。
在本研究中,SBBC和MBBC在总体人群中的发病率分别为1.39%和0.91%。在UBC与BBC、SBBC与MBBC的比较中,病理分期、激素受体(HR)状态和分子类型等常见临床病理特征存在显著差异。在BBC的手术治疗方面,49.72%的患者选择了乳房切除术。SBBC和MBBC的3年无病生存率(DFS)分别为94.4%和96.9%。SBBC和MBBC之间的总生存期(OS)和DFS无差异。双侧肿瘤的组织学分级和手术类型是BBC患者DFS的重要影响因素。
中国人群中SBBC和MBBC的临床病理特征及预后存在统计学差异。因此,BBC患者的治疗应个体化。